Archive for the ‘ori investigations’ Category
A former researcher at the University of Michigan and the University of Chicago faked dozens of experiments and images over the course of six years, according to a new finding from the Office of Research Integrity (ORI).
Ricky Malhotra, who studied heart cells, admitted to committing misconduct at both institutions, the ORI said in its report of the case. The fakery involved three National Institutes of Health (NIH) grant applications, one NIH progress report, one paper, seven presentations, and one image file. Despite an investigation at the University of Michigan, where Malhotra was from 2005-2006, he continued this falsification at [University of Chicago], after the [University of Michigan] research misconduct investigation was completed,” according to the ORI. The agency found that he Read the rest of this entry »
A researcher has agreed to a five-year ban on Federal U.S. funding for research after the Office of Research Integrity (ORI) determined that he had falsified or fabricated more than 40 images in nine papers.
The findings, released by the ORI today, are another chapter in a case involving John Pastorino, a cell biologist at Rowan University. In February, we reported that two journals had issued expressions of concern (EOCs) for six of his papers.
Pastorino, according to the ORI, Read the rest of this entry »
A former postdoc at the University of Pittsburgh has admitted to committing research misconduct in published papers and in National Institutes of Health (NIH) grant applications.
One Friday in January, graduate student Meredyth Forbes was reviewing material for her dissertation with her mentor when she decided to make a confession.
She “burst out with a statement that some of the data was fabricated,” said Edward Burns, research integrity officer at the Albert Einstein College of Medicine, where Forbes worked. It was, Burns told Retraction Watch: Read the rest of this entry »
The retractions come as part of a backstory of pulled papers authored by psychologist Edward Awh and his former graduate student David Anderson when he was based at the University of Oregon in Eugene. The pair retracted four papers last year after Anderson admitted to misconduct during an investigation by the U.S. Office of Research Integrity (and spoke to us about it last July). This led Awh — now based at the University of Chicago in Illinois — to take a second look at the other publications he’d co-authored with Anderson; earlier this year, Awh retracted two others, and informed us more would be coming, including the two most recent publications.
In May of last year, Stephanie Watkins, who now works at Loyola Medicine, earned two retractions, which mention a review by an investigation committee at the National Institutes of Health. Two of the new notes, published in Cancer Research, mention the review as well, and cite data falsification in a figure as the reason for retraction. Watkins is the only author that did not agree to those retractions.
There may be more changes to the literature — an editor at another cancer journal told us the journal is awaiting a decision from the Office of Research Integrity before deciding what to do with a paper by Watkins, given that she does not agree with the misconduct charges.
We’ll start with a retraction note from Cancer Research:
Authors have retracted two papers about visual perception and working memory from the Journal of Cognitive Neuroscience, after the first author admitted to falsifying or fabricating data in four other papers.
The authors have requested another two retractions, as well, which will bring the total for Edward Awh and his former graduate student David Anderson to nine retractions. (Earlier in 2015, they lost a paper due to an error in the analytic code, which Awh told us was unrelated to the misconduct.)
The retraction notice attached to both articles cites a 2015 settlement agreement between the Office of Research Integrity and first author Anderson (the “respondent”), who admitted to misconduct while working as a graduate student in the lab of Awh at the University of Oregon in Eugene. Since then, “additional problems” were discovered in the newly retracted articles, such as removed data points.
A paper flagged in an Office of Research Integrity notice more than one year ago has finally been retracted. According to the notice, the paper includes images manipulated by author H. Rosie Xing, a former University of Chicago cancer researcher.
The main conclusions of the paper are affected by the ORI finding, according to the retraction note from Molecular Cancer Therapeutics. But otherwise, the note contains information that was available in the ORI finding, published in December 2014.
“Pharmacologic Inactivation of Kinase Suppressor of Ras1 Sensitizes Epidermal Growth Factor Receptor and Oncogenic Ras-Dependent Tumors to Ionizing Radiation Treatment” has been cited seven times, according to Thomson Scientific’s Web of Knowledge — twice since the ORI finding came out.
The retraction note explains which images were affected by the manipulation:
The Office of Research Integrity’s findings are based on an inquiry at Virginia Commonwealth University, where Girija Dasmahapatra worked until July of this year, investigating possible therapies for cancer. The misconduct affected research funded by three grants from the National Institutes of Health. Steven Grant, a researcher at VCU, is the principal investigator on the grants, each of which total over $2 million in funding. All of the 11 affected papers will be corrected or retracted, according to the ORI notice.
Two of the papers containing “falsified and/or fabricated” data — a study on an experimental combination of drugs for blood cancer and one on chemotherapies for rare forms of lymphoma — were covered in press releases by VCU.
According to the notice in the Federal Register:
The director of the Research Integrity & Compliance Review Office at Colorado State University (CSU) is the new head of the U.S. Office of Research Integrity, taking over a position that has been vacant for more than a year and a half.